How We Treat: Colon And Rectal Cancer

Dr. Bleday dives into the findings of a recent study on role of organized religion in treatment with Professor Tyler VanderWeele. Dr. VanderWeele is the John L. Loeb and Frances Lehman Loeb Professor of Epidemiology at the Harvard School of Public Health.

Bleday and Meyerhardt discuss a trend in colorectal cancer cases involving younger patients, and some resources available for patients at the cancer care center.

With Dr. Leslie Lee

Episode #14 with Kimmie Ng.

Dr. Ron Bleday speaks with two guests to discuss colorectal cancer care in the island setting of Bermuda. His guests include Dr. Chris Fosker and Dr. Boris Vestweber.

Visit Howwetreat.org for full blog post. Drs. Bleday & Meyerhardt speak with Dr. Kevin Elias about Enhanced Recovery After Surgery methods and studies taking place right now in reducing stress on the patient's body pre-surgery. Even eating, hydrating, and carbohydrates are involved in prepping for common surgeries CRC doctors will want to learn more about.

Episode #11: Watch & Wait Protocol by Dana-Farber/Brigham and Women’s Cancer Center

Dr. Bleday and Dr. Meyerhardt discuss the International Duration Evaluation of Adjuvant chemotherapy project (IDEA) with Dr. Axel Grothey from the Mayo Clinic. Interview was recorded at the 2017 ASCO Conference in Chicago.

This episode features discussion on Heated Intraperitoneal Chemotherapy (HIPEC) treatment. The experts joining the podcast to discuss this type of care are Dr. Nelya Melnitchouk and Dr. Tom Abrams from the GI team at the Dana Farber/Brigham and Women's Cancer Center in Boston. HIPEC differs from other treatments because of the specific and targeted delivery method. The chemo does not circulate through the entire body during HIPEC. It only is directed at the cancerous cells in the abdomen area.

Episode #8 presents a case involving the treatment of an anal cancer patient that is also HIV positive. Dr. Harvey Mamon and Dr. Paul Sax discuss how this patient was successfully treated and the historical changes of how HIV cases have been treated in recent years. Visit the episode library at www.howwetreat.org for more info.

In the second part of our discussion on today's colorectal cancer trials, Dr. James Fleshman joins Ron to discuss the ACOSOG Z6051 Randomized Clinical Trial. This surgical trial aims to decipher the differences of open versus laparoscopic surgery in the treatment of colorectal cancer. In this episode, Jeff and Ron also answer a listener question and discuss the future of patient trials in this field.

The podcast's next two episodes will feature discussions around two recent and on-going clinical trials focused on patients with colon and rectal cancer. In episode #6, Dr. Deborah Schrag joins the podcast. She provides an inside look at the "Prospect" trial currently taking place. Visit howwetreat.org for more information.

Ron and Jeff discuss their care of a recent colorectal cancer patient with Lynch Syndrome. The episode explores the case's complications, immunotherapy, genetics, and steps in the treatment process when handling this type of case. Visit www.howwetreat.org to learn more about our guests and contact us. Enjoy!

In episode 4, the hosts discuss the complications and processes that are involved in treating a frail colorectal cancer patient. Visit www.howwetreat.org to enhance your listening experience.

Dr. Bleday speaks with two of his colleagues about a case in which some complications arose with a colitis patient who developed upper rectal cancer.

Episode 01 (Post Operative Chemo): In the first ever episode of the podcast, the DFCI presents a discussion between our host Ronald Bleday and his colleague, Dr. Marios Giannakis. They discuss a real colorectal cancer case involving the use of chemotherapy after GI surgery and radiation.

Dr. Michael Rosenthal joins the podcast to present a colorectal cancer case involving extensive work with various imaging practices for both treatment and diagnosis.